Metabolic dysfunction-associated steatotic liver disease (MASLD) was prevalent in more than 40% of patients with chronic hepatitis B and was independently associated with advanced fibrosis. This cross ...
More than 4.5 million Americans are living with chronic liver disease, putting them at risk for a variety of serious ...
A study from National Taiwan University Hospital has unveiled how metabolic dysfunction significantly influences the mortality risks of patients with chronic hepatitis B (CHB). The research, recently ...
Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and hepatocellular cancer (HCC, liver cancer). It affects approximately 296 million ...
Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are found. Staging assesses cancer's size, spread, and involvement of blood ...
Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When patients went off their medications, the virus started to come back — and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results